ArticleScientific reports2025
Investigating ferroptosis-related genes NFE2L2 in neutrophils for ankylosing spondylitis: therapeutic potential of cassia twigs.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nrf2 as a redox checkpoint in autoimmune joint inflammation: microenvironmental redox control across the arthritis spectrum.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
We determined the relationship between ferroptosis and immune cells in ankylosing spondylitis and the role of the Chinese herbal medicine Cassia twigs in treating ankylosing spondylitis. We analyzed clinical data on ankylosing spondylitis, transcriptome data, single-cell sequencing data, and genes related to ferroptosis and Cassia twigs. Clinical variables related to AS were selected through logistic regression analysis of the clinical data combined with machine learning. GSEA and enrichment analysis were performed on genes related to ferroptosis, combined with transcriptome data and drug-related genes, to identify the key genes and drug targets related to AS, as well as, the key immune cells. Then, the single-cell data and cell subtypes were analyzed. Finally, the interconnections between immune cells were analyzed through intercellular communication. Five variables, including neutrophils, were screened for clinical data analysis. The AUC of the experimental group was 0.859 and that of the validation group was 0.807. Ferroptosis gene NFE2L2 was identified as the final drug target of AS; it was upregulated in AS and downregulated in the control group by immunohistochemical verification, both of which were statistically significant (P < 0.001). Neutrophils were divided into two subgroups: high expression of NFE2L2 and low expression of NFE2L2. Through molecular docking, Cassia twigs were found to effectively act on the ferroptosis gene NFE2L2. Neutrophils act as important immune cells in AS. The twigs of the Chinese herb Cassia can treat AS by acting on the protein structure of the ferroptosis gene NFE2L2.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.